A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer
Clinical trial NCT01756638 · COMPLETED
Trial details
- NCT number
- NCT01756638
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-06
- Primary completion
- 2014-10-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.